Hepatocellular carcinoma. Epidemiology and etiological factors;Carcinoma hepatocelular. Epidemiología y factores etiológicos

Revista Espanola de Enfermedades Digestivas

Volumn 95, Issue 6, 2003, Pages 373-380

  Solis Herruzo J A ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN; ALPHA 1 ANTITRYPSIN; GROWTH FACTOR; PROTEIN P16; PROTEIN P53;

ALCOHOL LIVER CIRRHOSIS; ALPHA 1 ANTITRYPSIN DEFICIENCY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SUSCEPTIBILITY; DNA DAMAGE; EDITORIAL; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MITOSIS INHIBITION; ONCOGENE C MYC; ONCOGENE H RAS; PREVALENCE; VIRUS PATHOGENESIS;

EID: 0038792212     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (28)

1. Okuda K. Hepatocellular carcinoma. J Hepatol 2000; 32 (Supl. 1): 225-37.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: GLOBOCAN. Int J Cancer 2001; 94: 153-6.
3. Bosch J, Ribes J, Borrás J. Epidemiology of Primary Liver Cancer. Semin Liver Dis. 1999; 19: 271-85.
4. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745-50.
5. Zaman SN, Melia WM, Johnson RD, Portmann BC, Johnson PJ, Williams R. Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients. Lancet 1985; 1: 1357-60.
6. García-Torres ML, Zaragoza A, Giner R, Primo J, Olmo JA. Incidencia y factores epidemiológicos del carcinoma hepatocelular en Valencia durante el año 2000. Rev Esp Enferm Digest 2003; 95: 381-4.
7. Ozturk M. Genetic aspects of hepatocellular carcinogénesis. Semin Liver Dis 1999; 19: 235-42.
8. Nishida N, Fukuda Y, Kokuryu H, et al. Accumulation of allelic loss on arms of chromosomes 16q and 17p in the advanced stages of human hepatocellular carcinoma. Int J Cancer 1992; 51: 862-8.
9. Nagai H, Buendía MA. Oncogenes, tumor suppressors and cofactors in hepatocellular carcinoma. In: Caselmann WH, Koshy R, eds. Hepatitis B virus. Londres. Imperial College Press, 1998.
10. Cariani E, Lasserre C, Kemeny F, et al. Expression of insulin-like growth factor II, a-fetoprotein, and hepatitis B virus transcripts in human primary liver cancer. Hepatology 1991; 13: 644-9.
11. Chung YH, Kim JA, Song BC, et al. Expression of transforming growth factor-alpha mRNA in liver of patients with chronic viral hepatitis and hepatocellular carcinoma. Cancer 2000; 89: 977-82.
12. Ito T, Sasaki Y, Wands JR. Overexpression of human insulin receptor substrate 1 induces cellular transformation with activation of mitogen-activated protein kinases. Mol Cell Biol 1996; 16: 943-51.
13. Beasley RP, Hwang LY, Lin CC, Chein CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22707 men in Taiwan. Lancet 1981; ii: 1129-33.
14. Bréchot C, Pourcel C, Louise A, et al. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature 1980; 286: 533-5.
15. Edman JC, Gray P, Valenzuela P, et al. Integration of hepatitis B virus sequences and their expression in a human hepatoma cell. Nature 1980; 286: 535-8.
16. Koike K. HBV DNA integration and insertional mutagenesis. En: Caselmann WH, Koshy R, eds. Hepatitis B Virus. Londres. Imperial College Press, 1998.
17. Wang J, Zindy F, Chenivesse X, et al. Modification of cyclin A expression by hepatitis B virus integration in a hepatocellular carcinoma. Oncogene 1992; 7: 1653-6.
18. Zhou Y-Z, Slagle BL, Donehower LA, et al. Structural analysis of a hepatitis B virus genome integrated into chromosome 17p of a human hepatocellular carcinoma. J Virol 1988;62: 4224-31.
19. Tokino T, Matsubara K. Chromosomal sites for hepatitis B virus integration in human hepatocellular carcinoma. J Virol 1991; 65: 6761-4.
20. Feitelson MA. Hepatitis B x antigen and p53 in the development of hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 1998; 5: 367-74.
21. Andrisani OM, Barnabas S. The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis. Int J Ocol 1999; 15: 373-9.
22. Hildt E, Hofschneider PH. The PreS2 activators of the hepatitis B virus: activators of tumour promoter pathways. Recent Results Cancer Res 1998; 154: 315-29.
23. Colombo M. Hepatitis C virus and hepatocellular carcinoma Baillieres Best Pract Res Clin Gastroenterol 1999; 13: 519-28.
24. El-Serag HB. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 2002; 36: S74-S83.
25. Di Bisceglie AM. Hepatitis C and hepatocellular carcinoma. Hepatology 1997; 26 (Supl. 1): 34S-38S.
26. McLauchlan J. Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes. J Viral Hepat 2000; 7: 2-14.
27. Puisieux A, Ozturk M. TP53 and hepatocellular carcinoma. Pathol Biol (Paris) 1997; 45: 864-70.
28. Sylla A, Diallo MS, Castegnaro J, Wild CP. Interactions between hepatitis B virus infection and exposure to aflatoxins in the development of hepatocellular carcinoma: a molecular epidemiological approach. Mutat Res 1999; 428: 187-96.